Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Initiation of phase I/II study of OTO-313 in patients with tinnitus

April 12, 2019

Frequency Therapeutics reports phase I/II data on FX-322 for hearing restoration

April 9, 2019

Hearing loss gene therapy works in adult mice

March 12, 2019

Novel dual AAV-mediated gene therapy shows efficacy in DFNB9 mouse model

Feb. 26, 2019

Positive results announced from phase I study of LY-3056480 in sensorineural hearing loss

Feb. 7, 2019

Sound Pharmaceuticals enrolls first patient in STOP Ototoxicity phase II study of SPI-1005

Jan. 15, 2019

Spiral Therapeutics initiates phase I trial of new hearing loss drug, LPT-99

Dec. 19, 2018

Seliforant shown not to affect vigilance, cognitive performance during motion stimulus

Dec. 14, 2018

Novus initiates phase I trial of OP-0201 for otitis media

Nov. 29, 2018

Sensorion signs letter of intent with Institut Pasteur for hearing loss gene therapy programs

Nov. 23, 2018

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...